<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Open Forum Infect Dis</journal-id><journal-id journal-id-type="iso-abbrev">Open Forum Infect Dis</journal-id><journal-id journal-id-type="publisher-id">ofid</journal-id><journal-title-group><journal-title>Open Forum Infectious Diseases</journal-title></journal-title-group><issn pub-type="epub">2328-8957</issn><publisher><publisher-name>Oxford University Press</publisher-name><publisher-loc>US</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">5631474</article-id><article-id pub-id-type="doi">10.1093/ofid/ofx163.1247</article-id><article-id pub-id-type="publisher-id">ofx163.1247</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstracts</subject><subj-group subj-group-type="category-toc-heading"><subject>Poster Abstract</subject></subj-group></subj-group></article-categories><title-group><article-title>Clinical Outcome Evaluation of an Antimicrobial Stewardship Program in an Accountable Care Organization</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Baumgartner</surname><given-names>Meredith</given-names></name><degrees>MPH</degrees><xref ref-type="aff" rid="AF0001">1</xref></contrib><contrib contrib-type="author"><name><surname>Giddens</surname><given-names>Julie</given-names></name><degrees>PharmD BCPS</degrees><xref ref-type="aff" rid="AF0002">2</xref></contrib><contrib contrib-type="author"><name><surname>Asche</surname><given-names>Carl</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="AF0003">3</xref></contrib><contrib contrib-type="author"><name><surname>Ren</surname><given-names>Jinma</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="AF0003">3</xref></contrib><contrib contrib-type="author"><name><surname>Walayat</surname><given-names>Saqib</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="AF0001">1</xref></contrib><contrib contrib-type="author"><name><surname>Asghar</surname><given-names>Muhammad</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="AF0001">1</xref></contrib><contrib contrib-type="author"><name><surname>Cotter</surname><given-names>John</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="AF0004">4</xref></contrib></contrib-group><aff id="AF0001">
<label>1</label>
<institution>Medicine, University of Illinois College of Medicine at Peoria</institution>, <addr-line>Peoria, Illinois</addr-line></aff><aff id="AF0002">
<label>2</label>
<institution>Pharmacy, OSF Saint Francis Medical Center</institution>, <addr-line>Peoria, Illinois</addr-line></aff><aff id="AF0003">
<label>3</label>
<institution>Centers for Outcomes Research, University of Illinois College of Medicine at Peoria</institution>, <addr-line>Peoria, Illinois</addr-line></aff><aff id="AF0004">
<label>4</label>
<institution>Infectious Disease, University of Illinois College of Medicine at Peoria/ OSF Saint Francis Medical Center</institution>, <addr-line>Peoria, Illinois</addr-line></aff><author-notes><fn id="fn-0001"><p>
<bold>Session:</bold> 168. Stewardship: Improving Outcomes</p><p>
<italic>Friday, October 6, 2017: 12:30 PM</italic>
</p></fn></author-notes><pub-date pub-type="collection"><season>Fall</season><year>2017</year></pub-date><pub-date pub-type="epub" iso-8601-date="2017-10-04"><day>04</day><month>10</month><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>04</day><month>10</month><year>2017</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>4</volume><issue>Suppl 1</issue><issue-title>ID Week 2017 Abstracts</issue-title><fpage>S485</fpage><lpage>S485</lpage><permissions><copyright-statement>&#x000a9; The Author 2017. Published by Oxford University Press on behalf of Infectious Diseases Society of America.</copyright-statement><copyright-year>2017</copyright-year><license license-type="cc-by-nc-nd" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com</license-p></license></permissions><self-uri xlink:href="ofx163.1247.pdf"/><abstract><title>Abstract</title><sec id="s1"><title>Background</title><p>On a national level it is known that the daily misuse of antibiotics leads to delayed recovery, increased hospital length of stay, recurrent infection and even death. At the organization-level, antimicrobial stewardship programs have been developed to tackle these issues. As these programs develop, research is greatly needed to assess the associated clinical outcomes. This study was conducted to compare such clinical outcomes as length of stay (LOS), 30 day readmission and mortality pre and post implementation of a formal antimicrobial stewardship program.</p></sec><sec id="s2"><title>Methods</title><p>Retrospective review of randomized adult patients at a large community teaching facility receiving meropenem, linezolid, daptomycin, tigecycline, micafungin, vancomycin, piperacillin/tazobactam, levofloxacin, between April 2010 to March 2011 (Pre Intervention: <italic>n =</italic> 228) and April 2012 to March 2013 (Post Intervention: <italic>n =</italic> 219). The assessment of clinical outcomes was achieved using logistic regression for 30 day readmission and status of deceased on discharge, and a generalized linear model with gamma distribution for ICU LOS and inpatient LOS.</p></sec><sec id="s3"><title>Results</title><p>The Pre Intervention group had a 30 day readmission rate of 16.7% (38/228), a Status on Discharge of Deceased of 10.5% (24/228), an ICU LOS of 13.4% (14/228), and an Inpatient LOS of 11.6% (10.5/228). In contrast, the Post intervention group had a 30 day readmission rate of 7.3% (16/219; <italic>P =</italic> 0.001), a Status on Discharge of Deceased of 3.7% (8/219; <italic>P =</italic> 0.002), an ICU LOS of 9% (7.9/219; <italic>P =</italic> 0.01), and an Inpatient LOS of 8.8% (7.6/219; <italic>P =</italic> 0.018).</p></sec><sec id="s4"><title>Conclusion</title><p>The multidisciplinary efforts of the program were associated with statistical significant decreases in 30 day readmission rates, mortality on discharge and ICU and inpatient LOS. These results assist in validating the true clinical outcome benefits of antimicrobial stewardship programs.</p></sec><sec id="s5"><title>Disclosures</title><p>
<bold>All authors:</bold> No reported disclosures.</p></sec></abstract><counts><page-count count="1"/></counts></article-meta></front></article>